Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Development and validation of a HILIC- MS/MS multi-targeted method for metabolomics applications..
Electrophoresis.
(2015). Catamenial pneumothorax..
J Thorac Dis. 6(Suppl 4), S448-60.
(2014). Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study..
Lancet Neurol. 8(7), 619-27.
(2009). Distortion-product otoacoustic emissions testing in neonates treated with an aminoglycoside in a neonatal intensive care unit..
Ear Nose Throat J. 94(4-5), 156-65.
(2015). An alternative manoeuvre for posterior canal BPPV treatment..
B-ENT. 6(1), 9-13.
(2010). De novo Unbalanced 1;22 Translocation with 22q11 Deletion Syndrome..
Cytogenet Genome Res. 158(1), 32-37.
(2019). Correction to: The GEnetic Syntax Score: a genetic risk assessment implementation tool grading the complexity of coronary artery disease-rationale and design of the GESS study..
BMC Cardiovasc Disord. 21(1), 309.
(2021). The GEnetic Syntax Score: a genetic risk assessment implementation tool grading the complexity of coronary artery disease-rationale and design of the GESS study..
BMC Cardiovasc Disord. 21(1), 284.
(2021). Pure red cell aplasia and lymphoproliferative disorders: an infrequent association..
ScientificWorldJournal. 2012, 475313.
(2012). Evaluation of Mental Health and Physical Pain in Patients with β-Thalassemia Major in Northern Greece..
Hemoglobin. 39(3), 169-72.
(2015). Is there a role for low-dose eltrombopag as maintenance therapy in the treatment of immune thrombocytopenia?.
Acta Haematol. 133(1), 78-82.
(2015). Thrombotic thrombocytopenic purpura or immune thrombocytopenia in a sickle cell/β+-thalassemia patient: a rare and challenging condition..
Transfus Apher Sci. 51(2), 175-7.
(2014). Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition..
Hemoglobin. 42(5-6), 339-341.
(2018). Parotid gland oncocytoma: a case report..
Cases J. 2, 6423.
(2009). Is deferasirox implicated in multiple organ failure in a patient with homozygous β-thalassemia?.
Angiology. 62(4), 346-8.
(2011). Successful Outcome of Chronic Intrahepatic Cholestasis in an Adult Patient with Sickle Cell/ β (+) Thalassemia..
Case Rep Hematol. 2014, 213631.
(2014). Absence of JAK2V617F mutation in patients with beta-thalassemia major and thrombocytosis due to splenectomy..
Mol Biol Rep. 39(5), 6101-5.
(2012). Five Years of Deferasirox Therapy for Cardiac Iron in β-Thalassemia Major..
Hemoglobin. 39(5), 299-304.
(2015). Semapimod a new pretreatment modality of acute intestinal ischemia-reperfusion syndrome: experimental study in rabbits..
Int Angiol. 30(1), 35-42.
(2011). Cense: a tool to assess combined exposure to environmental health stressors in urban areas..
Environ Int. 63, 1-10.
(2014). DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions..
Nucleic Acids Res. 43(Database issue), D153-9.
(2015). Serum profiles of M30, M65 and interleukin-17 compared with C-reactive protein in patients with mild and severe acute pancreatitis..
J Hepatobiliary Pancreat Sci. 21(12), 911-8.
(2014). Surgical treatment of severe aortic valve stenosis with concomitant Fabry disease.
Cardiovascular Medicine.
(2019). Biochemical and imaging markers in patients with thalassaemia..
Hellenic J Cardiol.
(2020). Myomas and Adenomyosis: Impact on Reproductive Outcome..
Biomed Res Int. 2017, 5926470.
(2017).